BioCardia Shares Double After FDA Approves CardiAMP Trial
By Dean Seal Shares of BioCardia more than doubled after the company said regulators have approved a Phase 3 trial of its CardiAMP treatment for patients...
Source: marketwatch.com
Stay updated with breaking news from Executive Peter Altman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Dean Seal Shares of BioCardia more than doubled after the company said regulators have approved a Phase 3 trial of its CardiAMP treatment for patients...